Metastatic Digestive System Neuroendocrine Tumor G2
1 clinical trials · Condition
◉ Watch Metastatic Digestive System Neuroendocrine Tumor G2
| Record | Firm | Date |
|---|---|---|
| Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial (NCT05773274) | National Cancer Institute (NCI) | 2024-01-12 |
Track Metastatic Digestive System Neuroendocrine Tumor G2 automatically
Every clearance here is in the API, with alerts when new ones post.